Historically A Disappointment, Neuroprotective Drug Strategies Pursuing New Targets And Mechanisms
May 15th 2008Drug InformationAlzheimer's / Dementia News XML/RSS Feed
In terms of the number of people affected, neurological diseases that contributed to decline in neuronal function are sometimes considered the newest healthcare epidemic. With the number of cases of neurodegenerative conditions expected to grow dramatically, driven by the aging population in developed countries, this therapeutic area represents one of the most compelling in both commercial and human terms.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
